Device Dossier
LIAISON XL MUREX HIV Ab / Ag - HIV1/HIV2 antigen/antibody IVD, kit, chemiluminescent immunoassay
Device Dossier for LIAISON XL MUREX HIV Ab / Ag - HIV1/HIV2 antigen/antibody IVD, kit, chemiluminescent immunoassay (HIV1/HIV2 antigen/antibody IVD, kit,…
Intended purpose
For the combined qualitative determination of p24 antigen of human immunodeficiency virus type 1 (HIV-1) and specific antibodies to both human immunodeficiency virus type 1 (group M and group O) and/or human immunodeficiency virus type 2 (HIV-2) in human serum or plasma samples. Post mortem samples collected up to 24 hours after death have been tested and may be also used in the assay.
Functional description
The LIAISON® XL MUREX HIV Ab / Ag assay uses chemiluminescence immunoassay (CLIA) technology for the combined qualitative determination of p24 antigen of human immunodeficiency virus type 1 (HIV-1) and specific antibodies to both human immunodeficiency virus type 1 (group M and group O) and/or human immunodeficiency virus type 2 (HIV-2) in human serum or plasma samples